InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Lo Andrew, Director. Insider active across 2 companies, notably AbCellera Biologics Inc.. In total, 4 disclosures have been published. Total volume traded: €2.3m. The latest transaction was filed on 29 December 2021 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
€68,4066,000 shares@ €11.4010.0005% mcap100.0% of flow
Common Stock
SEC:0000899243-22-000188·
Ideal exit: 25 Sept 2022 (T+270)
€68,4066,000 shares@ €11.4010.0005% mcap50.0% of flow
Common Stock
SEC:0000899243-22-000188:0·
Ideal exit: 25 Sept 2022 (T+270)
€1m86,938 shares@ €12.40030.086% mcap100.0% of flow
Share Option (right to buy)
SEC:0001209191-21-068291·
Ideal exit: 30 Aug 2022 (T+270)
€1m86,938 shares@ €12.40030.086% mcap50.0% of flow
Share Option (right to buy)
SEC:0001209191-21-068291:0·
Ideal exit: 30 Aug 2022 (T+270)
4 of 4 declarations
About Lo Andrew
Andrew Lo is a Board Member at AbCellera Biologics Inc. and BridgeBio Pharma, Inc. In this role, he participates in the governance of these companies, bringing his expertise in biotechnology and life sciences.
